US BANCORP \DE\ - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 152 filers reported holding IMMUNOVANT INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$114,786
+104.5%
2,990
+1.0%
0.00%
Q2 2023$56,132
+20.6%
2,959
-1.4%
0.00%
Q1 2023$46,561
-11.3%
3,002
+1.5%
0.00%
Q4 2022$52,522
+556.5%
2,959
+114.9%
0.00%
Q3 2022$8,000
+166.7%
1,377
+113.2%
0.00%
Q2 2022$3,0000.0%646
+1.7%
0.00%
Q1 2022$3,000
-62.5%
635
-32.2%
0.00%
Q4 2021$8,000
-11.1%
937
-10.9%
0.00%
Q3 2021$9,0001,0520.00%
Other shareholders
IMMUNOVANT INC shareholders Q2 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 3,007,000$25,620,0003.77%
Deep Track Capital, LP 4,775,000$40,683,0002.87%
Octagon Capital Advisors LP 572,862$4,881,0000.95%
Eventide Asset Management 4,950,000$42,174,0000.54%
WITTENBERG INVESTMENT MANAGEMENT, INC. 140,500$1,197,0000.44%
FRAZIER MANAGEMENT LLC 585,759$4,991,0000.38%
MANGROVE PARTNERS IM, LLC 688,000$5,862,0000.35%
BCK CAPITAL MANAGEMENT LP 54,293$463,0000.31%
EcoR1 Capital, LLC 1,140,819$9,720,0000.31%
MANGROVE PARTNERS IM, LLC 570,400$4,860,0000.29%
View complete list of IMMUNOVANT INC shareholders